nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—HTR1D—migraine	0.159	0.328	CbGaD
Dihydroergotamine—HTR2B—migraine	0.157	0.324	CbGaD
Dihydroergotamine—HTR1B—migraine	0.0943	0.194	CbGaD
Dihydroergotamine—HTR1A—migraine	0.0746	0.154	CbGaD
Dihydroergotamine—HTR1B—Propranolol—migraine	0.0459	0.149	CbGbCtD
Dihydroergotamine—HTR6—Amitriptyline—migraine	0.0454	0.147	CbGbCtD
Dihydroergotamine—HTR1D—Amitriptyline—migraine	0.0414	0.134	CbGbCtD
Dihydroergotamine—HTR1B—Amitriptyline—migraine	0.0397	0.129	CbGbCtD
Dihydroergotamine—HTR1A—Propranolol—migraine	0.0288	0.0931	CbGbCtD
Dihydroergotamine—HTR1A—Amitriptyline—migraine	0.0249	0.0805	CbGbCtD
Dihydroergotamine—ADRA2A—Amitriptyline—migraine	0.0238	0.077	CbGbCtD
Dihydroergotamine—ABCB1—Timolol—migraine	0.0109	0.0353	CbGbCtD
Dihydroergotamine—ABCB1—Propranolol—migraine	0.00971	0.0314	CbGbCtD
Dihydroergotamine—HTR1B—trigeminal nucleus—migraine	0.00868	0.17	CbGeAlD
Dihydroergotamine—HTR1D—trigeminal nucleus—migraine	0.0084	0.165	CbGeAlD
Dihydroergotamine—ABCB1—Amitriptyline—migraine	0.0084	0.0272	CbGbCtD
Dihydroergotamine—ABCB1—Verapamil—migraine	0.00666	0.0216	CbGbCtD
Dihydroergotamine—CYP3A4—Propranolol—migraine	0.00582	0.0188	CbGbCtD
Dihydroergotamine—HTR1D—meninx—migraine	0.00558	0.109	CbGeAlD
Dihydroergotamine—HTR1B—dura mater—migraine	0.0053	0.104	CbGeAlD
Dihydroergotamine—HTR1D—dura mater—migraine	0.00513	0.101	CbGeAlD
Dihydroergotamine—CYP3A4—Amitriptyline—migraine	0.00503	0.0163	CbGbCtD
Dihydroergotamine—CYP3A4—Valproic Acid—migraine	0.00459	0.0148	CbGbCtD
Dihydroergotamine—CYP3A4—Topiramate—migraine	0.00414	0.0134	CbGbCtD
Dihydroergotamine—CYP3A4—Verapamil—migraine	0.00399	0.0129	CbGbCtD
Dihydroergotamine—HTR1B—trigeminal nerve—migraine	0.00228	0.0446	CbGeAlD
Dihydroergotamine—HTR1D—trigeminal nerve—migraine	0.00221	0.0432	CbGeAlD
Dihydroergotamine—HTR1B—cranial nerve—migraine	0.00162	0.0318	CbGeAlD
Dihydroergotamine—HTR1D—cranial nerve—migraine	0.00157	0.0308	CbGeAlD
Dihydroergotamine—HTR1B—blood vessel—migraine	0.000654	0.0128	CbGeAlD
Dihydroergotamine—HTR1D—blood vessel—migraine	0.000633	0.0124	CbGeAlD
Dihydroergotamine—ADRA2A—peripheral nervous system—migraine	0.000604	0.0118	CbGeAlD
Dihydroergotamine—Ergotamine—HTR1D—migraine	0.000476	0.123	CrCbGaD
Dihydroergotamine—Ergotamine—HTR2B—migraine	0.000471	0.122	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR1D—migraine	0.000459	0.118	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR2B—migraine	0.000455	0.117	CrCbGaD
Dihydroergotamine—HTR1B—trigeminal ganglion—migraine	0.000404	0.00791	CbGeAlD
Dihydroergotamine—HTR1D—trigeminal ganglion—migraine	0.000391	0.00766	CbGeAlD
Dihydroergotamine—HTR1B—brainstem—migraine	0.000357	0.007	CbGeAlD
Dihydroergotamine—HTR1D—brainstem—migraine	0.000346	0.00678	CbGeAlD
Dihydroergotamine—HTR6—head—migraine	0.000328	0.00642	CbGeAlD
Dihydroergotamine—HTR6—nervous system—migraine	0.000311	0.00608	CbGeAlD
Dihydroergotamine—HTR6—central nervous system—migraine	0.000299	0.00586	CbGeAlD
Dihydroergotamine—HTR1B—cardiovascular system—migraine	0.000292	0.00571	CbGeAlD
Dihydroergotamine—HTR1A—brainstem—migraine	0.000288	0.00565	CbGeAlD
Dihydroergotamine—Ergotamine—HTR1B—migraine	0.000283	0.0729	CrCbGaD
Dihydroergotamine—HTR1D—cardiovascular system—migraine	0.000282	0.00553	CbGeAlD
Dihydroergotamine—Bromocriptine—HTR7—migraine	0.000281	0.0726	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR1B—migraine	0.000273	0.0703	CrCbGaD
Dihydroergotamine—HTR2B—cardiovascular system—migraine	0.000263	0.00514	CbGeAlD
Dihydroergotamine—HTR6—brain—migraine	0.000237	0.00465	CbGeAlD
Dihydroergotamine—HTR1A—cardiovascular system—migraine	0.000235	0.00461	CbGeAlD
Dihydroergotamine—Ergotamine—HTR2C—migraine	0.00023	0.0594	CrCbGaD
Dihydroergotamine—ADRA2A—trigeminal ganglion—migraine	0.000228	0.00447	CbGeAlD
Dihydroergotamine—Ergotamine—HTR1A—migraine	0.000224	0.0577	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR2C—migraine	0.000222	0.0573	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR1A—migraine	0.000216	0.0556	CrCbGaD
Dihydroergotamine—ABCB1—blood vessel—migraine	0.000206	0.00403	CbGeAlD
Dihydroergotamine—HTR1B—head—migraine	0.000197	0.00387	CbGeAlD
Dihydroergotamine—HTR1D—head—migraine	0.000191	0.00374	CbGeAlD
Dihydroergotamine—HTR1B—nervous system—migraine	0.000187	0.00367	CbGeAlD
Dihydroergotamine—HTR1D—nervous system—migraine	0.000181	0.00355	CbGeAlD
Dihydroergotamine—HTR1B—central nervous system—migraine	0.00018	0.00353	CbGeAlD
Dihydroergotamine—HTR2B—head—migraine	0.000178	0.00348	CbGeAlD
Dihydroergotamine—HTR1D—central nervous system—migraine	0.000174	0.00342	CbGeAlD
Dihydroergotamine—HTR2B—nervous system—migraine	0.000169	0.0033	CbGeAlD
Dihydroergotamine—HTR2B—central nervous system—migraine	0.000162	0.00318	CbGeAlD
Dihydroergotamine—HTR1A—head—migraine	0.000159	0.00312	CbGeAlD
Dihydroergotamine—HTR1A—nervous system—migraine	0.000151	0.00296	CbGeAlD
Dihydroergotamine—Pain—Propranolol—migraine	0.000147	0.00179	CcSEcCtD
Dihydroergotamine—Sinusitis—Timolol—migraine	0.000147	0.00178	CcSEcCtD
Dihydroergotamine—Ergotamine—HTR2A—migraine	0.000147	0.0378	CrCbGaD
Dihydroergotamine—HTR1A—central nervous system—migraine	0.000145	0.00285	CbGeAlD
Dihydroergotamine—Diarrhoea—Amitriptyline—migraine	0.000145	0.00176	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Verapamil—migraine	0.000144	0.00175	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Gabapentin—migraine	0.000144	0.00175	CcSEcCtD
Dihydroergotamine—Insomnia—Verapamil—migraine	0.000143	0.00174	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Gabapentin—migraine	0.000143	0.00174	CcSEcCtD
Dihydroergotamine—HTR1B—brain—migraine	0.000143	0.0028	CbGeAlD
Dihydroergotamine—Paraesthesia—Verapamil—migraine	0.000142	0.00173	CcSEcCtD
Dihydroergotamine—HTR1A—cerebellum—migraine	0.000142	0.00278	CbGeAlD
Dihydroergotamine—Conjunctivitis—Gabapentin—migraine	0.000142	0.00172	CcSEcCtD
Dihydroergotamine—Chills—Valproic Acid—migraine	0.000142	0.00172	CcSEcCtD
Dihydroergotamine—Bromocriptine—HTR2A—migraine	0.000142	0.0365	CrCbGaD
Dihydroergotamine—Dyspnoea—Verapamil—migraine	0.000141	0.00171	CcSEcCtD
Dihydroergotamine—Rhinitis—Timolol—migraine	0.000141	0.00171	CcSEcCtD
Dihydroergotamine—Somnolence—Verapamil—migraine	0.000141	0.00171	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Propranolol—migraine	0.000141	0.00171	CcSEcCtD
Dihydroergotamine—Muscular weakness—Topiramate—migraine	0.000141	0.00171	CcSEcCtD
Dihydroergotamine—Dizziness—Amitriptyline—migraine	0.00014	0.0017	CcSEcCtD
Dihydroergotamine—Dyspepsia—Verapamil—migraine	0.000139	0.00169	CcSEcCtD
Dihydroergotamine—HTR1D—brain—migraine	0.000139	0.00271	CbGeAlD
Dihydroergotamine—Dysphagia—Topiramate—migraine	0.000138	0.00167	CcSEcCtD
Dihydroergotamine—Epistaxis—Gabapentin—migraine	0.000138	0.00167	CcSEcCtD
Dihydroergotamine—Sinusitis—Gabapentin—migraine	0.000137	0.00166	CcSEcCtD
Dihydroergotamine—Urticaria—Propranolol—migraine	0.000137	0.00166	CcSEcCtD
Dihydroergotamine—Fatigue—Verapamil—migraine	0.000137	0.00166	CcSEcCtD
Dihydroergotamine—Body temperature increased—Propranolol—migraine	0.000136	0.00165	CcSEcCtD
Dihydroergotamine—Abdominal pain—Propranolol—migraine	0.000136	0.00165	CcSEcCtD
Dihydroergotamine—Visual impairment—Timolol—migraine	0.000136	0.00165	CcSEcCtD
Dihydroergotamine—Pain—Verapamil—migraine	0.000136	0.00164	CcSEcCtD
Dihydroergotamine—Tension—Valproic Acid—migraine	0.000135	0.00164	CcSEcCtD
Dihydroergotamine—Vomiting—Amitriptyline—migraine	0.000135	0.00163	CcSEcCtD
Dihydroergotamine—Angina pectoris—Topiramate—migraine	0.000134	0.00163	CcSEcCtD
Dihydroergotamine—Sweating increased—Topiramate—migraine	0.000134	0.00163	CcSEcCtD
Dihydroergotamine—Nervousness—Valproic Acid—migraine	0.000134	0.00162	CcSEcCtD
Dihydroergotamine—Rash—Amitriptyline—migraine	0.000133	0.00162	CcSEcCtD
Dihydroergotamine—Dermatitis—Amitriptyline—migraine	0.000133	0.00162	CcSEcCtD
Dihydroergotamine—Headache—Amitriptyline—migraine	0.000133	0.00161	CcSEcCtD
Dihydroergotamine—Bronchitis—Topiramate—migraine	0.000133	0.00161	CcSEcCtD
Dihydroergotamine—Muscle spasms—Valproic Acid—migraine	0.000132	0.00161	CcSEcCtD
Dihydroergotamine—Rhinitis—Gabapentin—migraine	0.000131	0.00159	CcSEcCtD
Dihydroergotamine—Tinnitus—Timolol—migraine	0.000131	0.00159	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Verapamil—migraine	0.000131	0.00158	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Gabapentin—migraine	0.00013	0.00158	CcSEcCtD
Dihydroergotamine—Pharyngitis—Gabapentin—migraine	0.00013	0.00158	CcSEcCtD
Dihydroergotamine—Tremor—Valproic Acid—migraine	0.000129	0.00156	CcSEcCtD
Dihydroergotamine—HTR2B—brain—migraine	0.000129	0.00252	CbGeAlD
Dihydroergotamine—Upper respiratory tract infection—Topiramate—migraine	0.000128	0.00155	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Valproic Acid—migraine	0.000128	0.00155	CcSEcCtD
Dihydroergotamine—Pollakiuria—Topiramate—migraine	0.000127	0.00154	CcSEcCtD
Dihydroergotamine—ABCB1—trigeminal ganglion—migraine	0.000127	0.00249	CbGeAlD
Dihydroergotamine—Hypersensitivity—Propranolol—migraine	0.000127	0.00154	CcSEcCtD
Dihydroergotamine—Agitation—Valproic Acid—migraine	0.000127	0.00153	CcSEcCtD
Dihydroergotamine—Visual impairment—Gabapentin—migraine	0.000126	0.00153	CcSEcCtD
Dihydroergotamine—Urticaria—Verapamil—migraine	0.000126	0.00153	CcSEcCtD
Dihydroergotamine—Nausea—Amitriptyline—migraine	0.000126	0.00152	CcSEcCtD
Dihydroergotamine—Malaise—Valproic Acid—migraine	0.000124	0.00151	CcSEcCtD
Dihydroergotamine—Vertigo—Valproic Acid—migraine	0.000124	0.0015	CcSEcCtD
Dihydroergotamine—Asthenia—Propranolol—migraine	0.000124	0.0015	CcSEcCtD
Dihydroergotamine—Tinnitus—Gabapentin—migraine	0.000122	0.00148	CcSEcCtD
Dihydroergotamine—Palpitations—Valproic Acid—migraine	0.000122	0.00148	CcSEcCtD
Dihydroergotamine—Tension—Timolol—migraine	0.00012	0.00146	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Topiramate—migraine	0.000119	0.00145	CcSEcCtD
Dihydroergotamine—Nervousness—Timolol—migraine	0.000119	0.00144	CcSEcCtD
Dihydroergotamine—Hypertension—Valproic Acid—migraine	0.000119	0.00144	CcSEcCtD
Dihydroergotamine—Diarrhoea—Propranolol—migraine	0.000118	0.00143	CcSEcCtD
Dihydroergotamine—Chills—Gabapentin—migraine	0.000118	0.00143	CcSEcCtD
Dihydroergotamine—Myalgia—Valproic Acid—migraine	0.000117	0.00142	CcSEcCtD
Dihydroergotamine—Arthralgia—Valproic Acid—migraine	0.000117	0.00142	CcSEcCtD
Dihydroergotamine—Anxiety—Valproic Acid—migraine	0.000117	0.00142	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Verapamil—migraine	0.000117	0.00142	CcSEcCtD
Dihydroergotamine—Epistaxis—Topiramate—migraine	0.000116	0.00141	CcSEcCtD
Dihydroergotamine—Discomfort—Valproic Acid—migraine	0.000116	0.0014	CcSEcCtD
Dihydroergotamine—HTR1A—brain—migraine	0.000115	0.00226	CbGeAlD
Dihydroergotamine—Sinusitis—Topiramate—migraine	0.000115	0.0014	CcSEcCtD
Dihydroergotamine—Dry mouth—Valproic Acid—migraine	0.000115	0.00139	CcSEcCtD
Dihydroergotamine—Dizziness—Propranolol—migraine	0.000114	0.00138	CcSEcCtD
Dihydroergotamine—Asthenia—Verapamil—migraine	0.000114	0.00138	CcSEcCtD
Dihydroergotamine—Confusional state—Valproic Acid—migraine	0.000113	0.00137	CcSEcCtD
Dihydroergotamine—Oedema—Valproic Acid—migraine	0.000112	0.00136	CcSEcCtD
Dihydroergotamine—Pruritus—Verapamil—migraine	0.000112	0.00136	CcSEcCtD
Dihydroergotamine—Tension—Gabapentin—migraine	0.000112	0.00136	CcSEcCtD
Dihydroergotamine—ADRA2A—head—migraine	0.000112	0.00219	CbGeAlD
Dihydroergotamine—Nervousness—Gabapentin—migraine	0.000111	0.00134	CcSEcCtD
Dihydroergotamine—Rhinitis—Topiramate—migraine	0.000111	0.00134	CcSEcCtD
Dihydroergotamine—Vertigo—Timolol—migraine	0.00011	0.00134	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Topiramate—migraine	0.00011	0.00133	CcSEcCtD
Dihydroergotamine—Muscle spasms—Gabapentin—migraine	0.00011	0.00133	CcSEcCtD
Dihydroergotamine—Tachycardia—Valproic Acid—migraine	0.00011	0.00133	CcSEcCtD
Dihydroergotamine—Vomiting—Propranolol—migraine	0.00011	0.00133	CcSEcCtD
Dihydroergotamine—Pharyngitis—Topiramate—migraine	0.000109	0.00133	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Valproic Acid—migraine	0.000109	0.00132	CcSEcCtD
Dihydroergotamine—Rash—Propranolol—migraine	0.000109	0.00132	CcSEcCtD
Dihydroergotamine—Dermatitis—Propranolol—migraine	0.000109	0.00132	CcSEcCtD
Dihydroergotamine—Diarrhoea—Verapamil—migraine	0.000108	0.00131	CcSEcCtD
Dihydroergotamine—Palpitations—Timolol—migraine	0.000108	0.00131	CcSEcCtD
Dihydroergotamine—Anorexia—Valproic Acid—migraine	0.000107	0.0013	CcSEcCtD
Dihydroergotamine—Tremor—Gabapentin—migraine	0.000107	0.0013	CcSEcCtD
Dihydroergotamine—Visual impairment—Topiramate—migraine	0.000106	0.00129	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Gabapentin—migraine	0.000106	0.00128	CcSEcCtD
Dihydroergotamine—ADRA2A—nervous system—migraine	0.000106	0.00207	CbGeAlD
Dihydroergotamine—Hypertension—Timolol—migraine	0.000106	0.00128	CcSEcCtD
Dihydroergotamine—Hypotension—Valproic Acid—migraine	0.000105	0.00127	CcSEcCtD
Dihydroergotamine—Agitation—Gabapentin—migraine	0.000105	0.00127	CcSEcCtD
Dihydroergotamine—Dizziness—Verapamil—migraine	0.000105	0.00127	CcSEcCtD
Dihydroergotamine—Arthralgia—Timolol—migraine	0.000104	0.00127	CcSEcCtD
Dihydroergotamine—Myalgia—Timolol—migraine	0.000104	0.00127	CcSEcCtD
Dihydroergotamine—Anxiety—Timolol—migraine	0.000104	0.00126	CcSEcCtD
Dihydroergotamine—Discomfort—Timolol—migraine	0.000103	0.00125	CcSEcCtD
Dihydroergotamine—Malaise—Gabapentin—migraine	0.000103	0.00125	CcSEcCtD
Dihydroergotamine—Tinnitus—Topiramate—migraine	0.000103	0.00125	CcSEcCtD
Dihydroergotamine—Vertigo—Gabapentin—migraine	0.000103	0.00124	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Valproic Acid—migraine	0.000102	0.00124	CcSEcCtD
Dihydroergotamine—Flushing—Topiramate—migraine	0.000102	0.00124	CcSEcCtD
Dihydroergotamine—Nausea—Propranolol—migraine	0.000102	0.00124	CcSEcCtD
Dihydroergotamine—Dry mouth—Timolol—migraine	0.000102	0.00124	CcSEcCtD
Dihydroergotamine—ADRA2A—central nervous system—migraine	0.000102	0.002	CbGeAlD
Dihydroergotamine—Insomnia—Valproic Acid—migraine	0.000102	0.00123	CcSEcCtD
Dihydroergotamine—Paraesthesia—Valproic Acid—migraine	0.000101	0.00122	CcSEcCtD
Dihydroergotamine—Palpitations—Gabapentin—migraine	0.000101	0.00122	CcSEcCtD
Dihydroergotamine—Confusional state—Timolol—migraine	0.000101	0.00122	CcSEcCtD
Dihydroergotamine—Vomiting—Verapamil—migraine	0.000101	0.00122	CcSEcCtD
Dihydroergotamine—Dyspnoea—Valproic Acid—migraine	0.0001	0.00121	CcSEcCtD
Dihydroergotamine—Oedema—Timolol—migraine	0.0001	0.00121	CcSEcCtD
Dihydroergotamine—Rash—Verapamil—migraine	9.99e-05	0.00121	CcSEcCtD
Dihydroergotamine—Somnolence—Valproic Acid—migraine	9.99e-05	0.00121	CcSEcCtD
Dihydroergotamine—Dermatitis—Verapamil—migraine	9.98e-05	0.00121	CcSEcCtD
Dihydroergotamine—ADRA2A—cerebellum—migraine	9.96e-05	0.00195	CbGeAlD
Dihydroergotamine—Headache—Verapamil—migraine	9.93e-05	0.0012	CcSEcCtD
Dihydroergotamine—Chills—Topiramate—migraine	9.9e-05	0.0012	CcSEcCtD
Dihydroergotamine—Dyspepsia—Valproic Acid—migraine	9.89e-05	0.0012	CcSEcCtD
Dihydroergotamine—Hypertension—Gabapentin—migraine	9.85e-05	0.00119	CcSEcCtD
Dihydroergotamine—Shock—Timolol—migraine	9.84e-05	0.00119	CcSEcCtD
Dihydroergotamine—Decreased appetite—Valproic Acid—migraine	9.77e-05	0.00118	CcSEcCtD
Dihydroergotamine—Myalgia—Gabapentin—migraine	9.72e-05	0.00118	CcSEcCtD
Dihydroergotamine—Arthralgia—Gabapentin—migraine	9.72e-05	0.00118	CcSEcCtD
Dihydroergotamine—Fatigue—Valproic Acid—migraine	9.69e-05	0.00117	CcSEcCtD
Dihydroergotamine—Anxiety—Gabapentin—migraine	9.68e-05	0.00117	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Timolol—migraine	9.67e-05	0.00117	CcSEcCtD
Dihydroergotamine—Pain—Valproic Acid—migraine	9.61e-05	0.00117	CcSEcCtD
Dihydroergotamine—Discomfort—Gabapentin—migraine	9.6e-05	0.00116	CcSEcCtD
Dihydroergotamine—Anorexia—Timolol—migraine	9.53e-05	0.00116	CcSEcCtD
Dihydroergotamine—Dry mouth—Gabapentin—migraine	9.5e-05	0.00115	CcSEcCtD
Dihydroergotamine—Tension—Topiramate—migraine	9.42e-05	0.00114	CcSEcCtD
Dihydroergotamine—Nausea—Verapamil—migraine	9.41e-05	0.00114	CcSEcCtD
Dihydroergotamine—Confusional state—Gabapentin—migraine	9.39e-05	0.00114	CcSEcCtD
Dihydroergotamine—Hypotension—Timolol—migraine	9.35e-05	0.00113	CcSEcCtD
Dihydroergotamine—Nervousness—Topiramate—migraine	9.33e-05	0.00113	CcSEcCtD
Dihydroergotamine—Oedema—Gabapentin—migraine	9.31e-05	0.00113	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Valproic Acid—migraine	9.26e-05	0.00112	CcSEcCtD
Dihydroergotamine—Muscle spasms—Topiramate—migraine	9.23e-05	0.00112	CcSEcCtD
Dihydroergotamine—ABCB1—cardiovascular system—migraine	9.19e-05	0.0018	CbGeAlD
Dihydroergotamine—Gastrointestinal pain—Valproic Acid—migraine	9.19e-05	0.00111	CcSEcCtD
Dihydroergotamine—Shock—Gabapentin—migraine	9.16e-05	0.00111	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Timolol—migraine	9.11e-05	0.00111	CcSEcCtD
Dihydroergotamine—Tachycardia—Gabapentin—migraine	9.09e-05	0.0011	CcSEcCtD
Dihydroergotamine—Insomnia—Timolol—migraine	9.05e-05	0.0011	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Gabapentin—migraine	9e-05	0.00109	CcSEcCtD
Dihydroergotamine—Tremor—Topiramate—migraine	9e-05	0.00109	CcSEcCtD
Dihydroergotamine—Paraesthesia—Timolol—migraine	8.98e-05	0.00109	CcSEcCtD
Dihydroergotamine—Urticaria—Valproic Acid—migraine	8.93e-05	0.00108	CcSEcCtD
Dihydroergotamine—Dyspnoea—Timolol—migraine	8.92e-05	0.00108	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Topiramate—migraine	8.91e-05	0.00108	CcSEcCtD
Dihydroergotamine—Somnolence—Timolol—migraine	8.89e-05	0.00108	CcSEcCtD
Dihydroergotamine—Abdominal pain—Valproic Acid—migraine	8.88e-05	0.00108	CcSEcCtD
Dihydroergotamine—Body temperature increased—Valproic Acid—migraine	8.88e-05	0.00108	CcSEcCtD
Dihydroergotamine—Anorexia—Gabapentin—migraine	8.88e-05	0.00108	CcSEcCtD
Dihydroergotamine—Agitation—Topiramate—migraine	8.82e-05	0.00107	CcSEcCtD
Dihydroergotamine—Dyspepsia—Timolol—migraine	8.8e-05	0.00107	CcSEcCtD
Dihydroergotamine—Hypotension—Gabapentin—migraine	8.7e-05	0.00106	CcSEcCtD
Dihydroergotamine—Decreased appetite—Timolol—migraine	8.69e-05	0.00105	CcSEcCtD
Dihydroergotamine—Malaise—Topiramate—migraine	8.66e-05	0.00105	CcSEcCtD
Dihydroergotamine—Vertigo—Topiramate—migraine	8.63e-05	0.00105	CcSEcCtD
Dihydroergotamine—Fatigue—Timolol—migraine	8.62e-05	0.00105	CcSEcCtD
Dihydroergotamine—Pain—Timolol—migraine	8.55e-05	0.00104	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Gabapentin—migraine	8.49e-05	0.00103	CcSEcCtD
Dihydroergotamine—Palpitations—Topiramate—migraine	8.48e-05	0.00103	CcSEcCtD
Dihydroergotamine—Insomnia—Gabapentin—migraine	8.42e-05	0.00102	CcSEcCtD
Dihydroergotamine—Paraesthesia—Gabapentin—migraine	8.36e-05	0.00101	CcSEcCtD
Dihydroergotamine—CYP3A4—nervous system—migraine	8.33e-05	0.00163	CbGeAlD
Dihydroergotamine—Dyspnoea—Gabapentin—migraine	8.3e-05	0.00101	CcSEcCtD
Dihydroergotamine—Hypertension—Topiramate—migraine	8.29e-05	0.00101	CcSEcCtD
Dihydroergotamine—Somnolence—Gabapentin—migraine	8.28e-05	0.001	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Valproic Acid—migraine	8.28e-05	0.001	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Timolol—migraine	8.24e-05	0.001	CcSEcCtD
Dihydroergotamine—Dyspepsia—Gabapentin—migraine	8.2e-05	0.000994	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Timolol—migraine	8.18e-05	0.000992	CcSEcCtD
Dihydroergotamine—Myalgia—Topiramate—migraine	8.17e-05	0.000991	CcSEcCtD
Dihydroergotamine—Arthralgia—Topiramate—migraine	8.17e-05	0.000991	CcSEcCtD
Dihydroergotamine—Anxiety—Topiramate—migraine	8.15e-05	0.000988	CcSEcCtD
Dihydroergotamine—Decreased appetite—Gabapentin—migraine	8.1e-05	0.000982	CcSEcCtD
Dihydroergotamine—ADRA2A—brain—migraine	8.09e-05	0.00159	CbGeAlD
Dihydroergotamine—Discomfort—Topiramate—migraine	8.08e-05	0.000979	CcSEcCtD
Dihydroergotamine—Asthenia—Valproic Acid—migraine	8.06e-05	0.000978	CcSEcCtD
Dihydroergotamine—Fatigue—Gabapentin—migraine	8.03e-05	0.000974	CcSEcCtD
Dihydroergotamine—CYP3A4—central nervous system—migraine	8.02e-05	0.00157	CbGeAlD
Dihydroergotamine—Dry mouth—Topiramate—migraine	7.99e-05	0.000969	CcSEcCtD
Dihydroergotamine—Pain—Gabapentin—migraine	7.96e-05	0.000966	CcSEcCtD
Dihydroergotamine—Pruritus—Valproic Acid—migraine	7.95e-05	0.000964	CcSEcCtD
Dihydroergotamine—Urticaria—Timolol—migraine	7.95e-05	0.000964	CcSEcCtD
Dihydroergotamine—Abdominal pain—Timolol—migraine	7.91e-05	0.000959	CcSEcCtD
Dihydroergotamine—Body temperature increased—Timolol—migraine	7.91e-05	0.000959	CcSEcCtD
Dihydroergotamine—Confusional state—Topiramate—migraine	7.9e-05	0.000958	CcSEcCtD
Dihydroergotamine—Oedema—Topiramate—migraine	7.84e-05	0.00095	CcSEcCtD
Dihydroergotamine—Shock—Topiramate—migraine	7.71e-05	0.000935	CcSEcCtD
Dihydroergotamine—Diarrhoea—Valproic Acid—migraine	7.69e-05	0.000932	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Gabapentin—migraine	7.68e-05	0.000931	CcSEcCtD
Dihydroergotamine—Tachycardia—Topiramate—migraine	7.65e-05	0.000927	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Gabapentin—migraine	7.62e-05	0.000924	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Topiramate—migraine	7.58e-05	0.000919	CcSEcCtD
Dihydroergotamine—Anorexia—Topiramate—migraine	7.47e-05	0.000906	CcSEcCtD
Dihydroergotamine—Dizziness—Valproic Acid—migraine	7.43e-05	0.000901	CcSEcCtD
Dihydroergotamine—Urticaria—Gabapentin—migraine	7.4e-05	0.000897	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Timolol—migraine	7.37e-05	0.000894	CcSEcCtD
Dihydroergotamine—Body temperature increased—Gabapentin—migraine	7.36e-05	0.000893	CcSEcCtD
Dihydroergotamine—Abdominal pain—Gabapentin—migraine	7.36e-05	0.000893	CcSEcCtD
Dihydroergotamine—Hypotension—Topiramate—migraine	7.32e-05	0.000888	CcSEcCtD
Dihydroergotamine—Asthenia—Timolol—migraine	7.18e-05	0.00087	CcSEcCtD
Dihydroergotamine—Vomiting—Valproic Acid—migraine	7.14e-05	0.000866	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Topiramate—migraine	7.14e-05	0.000866	CcSEcCtD
Dihydroergotamine—Insomnia—Topiramate—migraine	7.09e-05	0.000859	CcSEcCtD
Dihydroergotamine—Rash—Valproic Acid—migraine	7.08e-05	0.000859	CcSEcCtD
Dihydroergotamine—Dermatitis—Valproic Acid—migraine	7.08e-05	0.000858	CcSEcCtD
Dihydroergotamine—Pruritus—Timolol—migraine	7.08e-05	0.000858	CcSEcCtD
Dihydroergotamine—Headache—Valproic Acid—migraine	7.04e-05	0.000854	CcSEcCtD
Dihydroergotamine—Paraesthesia—Topiramate—migraine	7.04e-05	0.000853	CcSEcCtD
Dihydroergotamine—Dyspnoea—Topiramate—migraine	6.99e-05	0.000847	CcSEcCtD
Dihydroergotamine—Somnolence—Topiramate—migraine	6.97e-05	0.000845	CcSEcCtD
Dihydroergotamine—Dyspepsia—Topiramate—migraine	6.9e-05	0.000836	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Gabapentin—migraine	6.86e-05	0.000832	CcSEcCtD
Dihydroergotamine—Diarrhoea—Timolol—migraine	6.84e-05	0.00083	CcSEcCtD
Dihydroergotamine—Decreased appetite—Topiramate—migraine	6.81e-05	0.000826	CcSEcCtD
Dihydroergotamine—Fatigue—Topiramate—migraine	6.76e-05	0.000819	CcSEcCtD
Dihydroergotamine—Pain—Topiramate—migraine	6.7e-05	0.000813	CcSEcCtD
Dihydroergotamine—Asthenia—Gabapentin—migraine	6.68e-05	0.00081	CcSEcCtD
Dihydroergotamine—Nausea—Valproic Acid—migraine	6.67e-05	0.000809	CcSEcCtD
Dihydroergotamine—Dizziness—Timolol—migraine	6.61e-05	0.000802	CcSEcCtD
Dihydroergotamine—Pruritus—Gabapentin—migraine	6.59e-05	0.000799	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Topiramate—migraine	6.46e-05	0.000783	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Topiramate—migraine	6.41e-05	0.000777	CcSEcCtD
Dihydroergotamine—Diarrhoea—Gabapentin—migraine	6.37e-05	0.000773	CcSEcCtD
Dihydroergotamine—Vomiting—Timolol—migraine	6.36e-05	0.000771	CcSEcCtD
Dihydroergotamine—Rash—Timolol—migraine	6.31e-05	0.000765	CcSEcCtD
Dihydroergotamine—Dermatitis—Timolol—migraine	6.3e-05	0.000764	CcSEcCtD
Dihydroergotamine—Headache—Timolol—migraine	6.27e-05	0.00076	CcSEcCtD
Dihydroergotamine—Urticaria—Topiramate—migraine	6.22e-05	0.000755	CcSEcCtD
Dihydroergotamine—ABCB1—head—migraine	6.22e-05	0.00122	CbGeAlD
Dihydroergotamine—Body temperature increased—Topiramate—migraine	6.19e-05	0.000751	CcSEcCtD
Dihydroergotamine—Abdominal pain—Topiramate—migraine	6.19e-05	0.000751	CcSEcCtD
Dihydroergotamine—Dizziness—Gabapentin—migraine	6.16e-05	0.000747	CcSEcCtD
Dihydroergotamine—Nausea—Timolol—migraine	5.94e-05	0.00072	CcSEcCtD
Dihydroergotamine—Vomiting—Gabapentin—migraine	5.92e-05	0.000718	CcSEcCtD
Dihydroergotamine—ABCB1—nervous system—migraine	5.9e-05	0.00116	CbGeAlD
Dihydroergotamine—Rash—Gabapentin—migraine	5.87e-05	0.000712	CcSEcCtD
Dihydroergotamine—Dermatitis—Gabapentin—migraine	5.87e-05	0.000712	CcSEcCtD
Dihydroergotamine—Headache—Gabapentin—migraine	5.83e-05	0.000708	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Topiramate—migraine	5.77e-05	0.0007	CcSEcCtD
Dihydroergotamine—ABCB1—central nervous system—migraine	5.68e-05	0.00111	CbGeAlD
Dihydroergotamine—Asthenia—Topiramate—migraine	5.62e-05	0.000682	CcSEcCtD
Dihydroergotamine—ABCB1—cerebellum—migraine	5.55e-05	0.00109	CbGeAlD
Dihydroergotamine—Pruritus—Topiramate—migraine	5.54e-05	0.000672	CcSEcCtD
Dihydroergotamine—Nausea—Gabapentin—migraine	5.53e-05	0.000671	CcSEcCtD
Dihydroergotamine—Diarrhoea—Topiramate—migraine	5.36e-05	0.00065	CcSEcCtD
Dihydroergotamine—Dizziness—Topiramate—migraine	5.18e-05	0.000628	CcSEcCtD
Dihydroergotamine—Vomiting—Topiramate—migraine	4.98e-05	0.000604	CcSEcCtD
Dihydroergotamine—Rash—Topiramate—migraine	4.94e-05	0.000599	CcSEcCtD
Dihydroergotamine—Dermatitis—Topiramate—migraine	4.94e-05	0.000599	CcSEcCtD
Dihydroergotamine—Headache—Topiramate—migraine	4.91e-05	0.000595	CcSEcCtD
Dihydroergotamine—Nausea—Topiramate—migraine	4.65e-05	0.000564	CcSEcCtD
Dihydroergotamine—ABCB1—brain—migraine	4.51e-05	0.000883	CbGeAlD
Dihydroergotamine—HTR1B—Signaling Pathways—CALCRL—migraine	3.17e-05	0.000463	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—RAMP1—migraine	3.17e-05	0.000463	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.07e-05	0.000448	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—CALCA—migraine	3.06e-05	0.000446	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HTR2B—migraine	3.04e-05	0.000444	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	2.99e-05	0.000436	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RAMP1—migraine	2.98e-05	0.000435	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CALCRL—migraine	2.98e-05	0.000435	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR1D—migraine	2.97e-05	0.000434	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.95e-05	0.000431	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—HTR7—migraine	2.86e-05	0.000417	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR2B—migraine	2.76e-05	0.000403	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HTR1B—migraine	2.76e-05	0.000403	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—HTR2A—migraine	2.7e-05	0.000395	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—HTR2A—migraine	2.68e-05	0.000392	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HTR1B—migraine	2.68e-05	0.000391	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HTR1B—migraine	2.66e-05	0.000388	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HTR1A—migraine	2.66e-05	0.000388	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.63e-05	0.000384	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—HTR2A—migraine	2.63e-05	0.000384	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—TAC1—migraine	2.62e-05	0.000382	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—NPS—migraine	2.62e-05	0.000382	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HTR1A—migraine	2.58e-05	0.000376	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	2.57e-05	0.000376	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HTR2C—migraine	2.57e-05	0.000374	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HTR1A—migraine	2.56e-05	0.000374	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—TAC1—migraine	2.54e-05	0.000371	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—NPS—migraine	2.54e-05	0.000371	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—NPS—migraine	2.52e-05	0.000368	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—TAC1—migraine	2.52e-05	0.000368	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.51e-05	0.000366	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HTR1A—migraine	2.51e-05	0.000366	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—EDNRA—migraine	2.5e-05	0.000364	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HTR2C—migraine	2.49e-05	0.000364	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HTR2C—migraine	2.47e-05	0.000361	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—NPS—migraine	2.47e-05	0.00036	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—TAC1—migraine	2.47e-05	0.00036	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—HTR2A—migraine	2.47e-05	0.00036	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HTR1B—migraine	2.45e-05	0.000357	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HTR1B—migraine	2.43e-05	0.000355	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—EDNRA—migraine	2.42e-05	0.000354	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HTR2C—migraine	2.42e-05	0.000353	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RAMP1—migraine	2.42e-05	0.000353	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CALCRL—migraine	2.42e-05	0.000353	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HTR1B—migraine	2.42e-05	0.000352	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.41e-05	0.000352	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—EDNRA—migraine	2.41e-05	0.000351	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CALCA—migraine	2.4e-05	0.000351	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	2.39e-05	0.000349	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR1D—migraine	2.37e-05	0.000346	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—EDNRA—migraine	2.36e-05	0.000344	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HTR1A—migraine	2.35e-05	0.000344	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HTR1A—migraine	2.34e-05	0.000342	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR1D—migraine	2.34e-05	0.000341	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CALCA—migraine	2.33e-05	0.00034	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HTR1A—migraine	2.32e-05	0.000339	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—NPS—migraine	2.32e-05	0.000338	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—TAC1—migraine	2.32e-05	0.000338	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CALCA—migraine	2.32e-05	0.000338	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—TAC1—migraine	2.31e-05	0.000337	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—NPS—migraine	2.31e-05	0.000337	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR1D—migraine	2.31e-05	0.000337	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—NPS—migraine	2.29e-05	0.000334	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—TAC1—migraine	2.29e-05	0.000334	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HTR1A—migraine	2.28e-05	0.000332	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HTR2C—migraine	2.27e-05	0.000332	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CALCA—migraine	2.27e-05	0.000331	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HTR2C—migraine	2.26e-05	0.00033	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HTR7—migraine	2.25e-05	0.000328	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HTR2C—migraine	2.25e-05	0.000328	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—NPS—migraine	2.24e-05	0.000327	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—TAC1—migraine	2.24e-05	0.000327	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HTR1B—migraine	2.22e-05	0.000324	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—EDNRA—migraine	2.21e-05	0.000323	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR2B—migraine	2.21e-05	0.000322	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—EDNRA—migraine	2.2e-05	0.000321	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HTR2C—migraine	2.2e-05	0.000321	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR2B—migraine	2.19e-05	0.00032	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—EDNRA—migraine	2.18e-05	0.000319	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HTR7—migraine	2.18e-05	0.000318	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR2B—migraine	2.17e-05	0.000317	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR1D—migraine	2.17e-05	0.000316	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HTR7—migraine	2.17e-05	0.000316	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR2B—migraine	2.14e-05	0.000313	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—EDNRA—migraine	2.14e-05	0.000312	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HTR1A—migraine	2.14e-05	0.000312	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CALCA—migraine	2.13e-05	0.000311	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HTR7—migraine	2.12e-05	0.000309	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CALCA—migraine	2.12e-05	0.000309	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—TAC1—migraine	2.11e-05	0.000307	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—NPS—migraine	2.11e-05	0.000307	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CALCA—migraine	2.1e-05	0.000307	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.07e-05	0.000302	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HTR2C—migraine	2.07e-05	0.000301	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CALCA—migraine	2.06e-05	0.0003	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—EDNRA—migraine	2.01e-05	0.000293	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—HTR2A—migraine	2e-05	0.000292	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HTR7—migraine	1.99e-05	0.000291	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HTR1B—migraine	1.98e-05	0.00029	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HTR7—migraine	1.98e-05	0.000289	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—TNF—migraine	1.97e-05	0.000288	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HTR7—migraine	1.97e-05	0.000287	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—LRP1—migraine	1.94e-05	0.000283	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CALCA—migraine	1.93e-05	0.000282	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—LRP1—migraine	1.93e-05	0.000281	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HTR7—migraine	1.93e-05	0.000281	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RAMP1—migraine	1.9e-05	0.000277	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CALCRL—migraine	1.9e-05	0.000277	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—LRP1—migraine	1.89e-05	0.000275	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.88e-05	0.000275	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—TAC1—migraine	1.88e-05	0.000274	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—NPS—migraine	1.88e-05	0.000274	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—TNF—migraine	1.85e-05	0.00027	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HTR2C—migraine	1.84e-05	0.000269	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HTR7—migraine	1.81e-05	0.000264	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR1B—migraine	1.8e-05	0.000263	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—EDNRA—migraine	1.79e-05	0.000262	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—LRP1—migraine	1.77e-05	0.000259	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR1D—migraine	1.76e-05	0.000256	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CALCA—migraine	1.73e-05	0.000252	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CACNA1A—migraine	1.72e-05	0.000251	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—TAC1—migraine	1.71e-05	0.000249	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—NPS—migraine	1.71e-05	0.000249	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR2C—migraine	1.67e-05	0.000244	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR2B—migraine	1.63e-05	0.000238	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—EDNRA—migraine	1.63e-05	0.000238	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HTR7—migraine	1.62e-05	0.000236	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HTR2A—migraine	1.57e-05	0.00023	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CALCA—migraine	1.57e-05	0.000229	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	1.56e-05	0.000228	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HTR2A—migraine	1.53e-05	0.000223	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HTR2A—migraine	1.52e-05	0.000221	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	1.5e-05	0.000219	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NOTCH4—migraine	1.49e-05	0.000217	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HTR2A—migraine	1.49e-05	0.000217	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NOTCH4—migraine	1.48e-05	0.000216	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—NPS—migraine	1.48e-05	0.000216	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—TAC1—migraine	1.48e-05	0.000216	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR7—migraine	1.47e-05	0.000214	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	1.45e-05	0.000212	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NOTCH4—migraine	1.45e-05	0.000211	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—LRP1—migraine	1.44e-05	0.00021	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR1B—migraine	1.44e-05	0.00021	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR1B—migraine	1.43e-05	0.000208	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR1B—migraine	1.42e-05	0.000207	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	1.41e-05	0.000206	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HTR2A—migraine	1.4e-05	0.000204	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HTR2A—migraine	1.39e-05	0.000203	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR1A—migraine	1.38e-05	0.000202	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR1D—migraine	1.38e-05	0.000201	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HTR2A—migraine	1.38e-05	0.000201	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR1A—migraine	1.37e-05	0.0002	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR1A—migraine	1.36e-05	0.000199	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NPS—migraine	1.36e-05	0.000199	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PGR—migraine	1.36e-05	0.000199	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TAC1—migraine	1.36e-05	0.000199	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NOTCH4—migraine	1.36e-05	0.000199	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CALCA—migraine	1.36e-05	0.000198	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NPS—migraine	1.35e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TAC1—migraine	1.35e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PGR—migraine	1.35e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HTR2A—migraine	1.35e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR1A—migraine	1.34e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TAC1—migraine	1.34e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—NPS—migraine	1.34e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR2C—migraine	1.34e-05	0.000195	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR2C—migraine	1.33e-05	0.000194	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TAC1—migraine	1.32e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NPS—migraine	1.32e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PGR—migraine	1.32e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR2C—migraine	1.32e-05	0.000192	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR1B—migraine	1.31e-05	0.000192	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—EDNRA—migraine	1.3e-05	0.00019	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR2C—migraine	1.3e-05	0.00019	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—EDNRA—migraine	1.29e-05	0.000188	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2B—migraine	1.28e-05	0.000187	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—EDNRA—migraine	1.28e-05	0.000187	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR7—migraine	1.27e-05	0.000185	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NOTCH3—migraine	1.27e-05	0.000185	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HTR2A—migraine	1.27e-05	0.000185	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—EDNRA—migraine	1.26e-05	0.000184	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR1A—migraine	1.26e-05	0.000184	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NOTCH3—migraine	1.26e-05	0.000184	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CALCA—migraine	1.25e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TAC1—migraine	1.24e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PGR—migraine	1.24e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NPS—migraine	1.24e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CALCA—migraine	1.24e-05	0.000181	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CALCA—migraine	1.23e-05	0.00018	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NOTCH3—migraine	1.23e-05	0.00018	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR2C—migraine	1.22e-05	0.000178	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CALCA—migraine	1.22e-05	0.000177	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CACNA1A—migraine	1.19e-05	0.000174	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—EDNRA—migraine	1.19e-05	0.000173	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR7—migraine	1.17e-05	0.000171	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR7—migraine	1.16e-05	0.00017	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NOTCH3—migraine	1.16e-05	0.000169	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR7—migraine	1.15e-05	0.000168	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CALCA—migraine	1.14e-05	0.000167	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR7—migraine	1.14e-05	0.000166	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HTR2A—migraine	1.13e-05	0.000165	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—LRP1—migraine	1.13e-05	0.000165	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NOTCH4—migraine	1.1e-05	0.000161	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR7—migraine	1.07e-05	0.000156	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR1B—migraine	1.06e-05	0.000155	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR2A—migraine	1.03e-05	0.00015	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NPS—migraine	1.01e-05	0.000147	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TAC1—migraine	1.01e-05	0.000147	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PGR—migraine	1.01e-05	0.000147	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TGFBR2—migraine	1.01e-05	0.000147	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TGFBR2—migraine	1e-05	0.000146	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR2C—migraine	9.89e-06	0.000144	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TGFBR2—migraine	9.8e-06	0.000143	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—EDNRA—migraine	9.62e-06	0.00014	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NOTCH3—migraine	9.38e-06	0.000137	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CALCA—migraine	9.26e-06	0.000135	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TGFBR2—migraine	9.2e-06	0.000134	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	9.12e-06	0.000133	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	8.89e-06	0.00013	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOTCH4—migraine	8.67e-06	0.000127	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR7—migraine	8.67e-06	0.000126	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR1B—migraine	8.36e-06	0.000122	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR2A—migraine	8.2e-06	0.00012	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR2A—migraine	8.14e-06	0.000119	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR2A—migraine	8.08e-06	0.000118	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR1A—migraine	8.05e-06	0.000118	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR2A—migraine	7.97e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TAC1—migraine	7.93e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PGR—migraine	7.93e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NPS—migraine	7.93e-06	0.000116	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2C—migraine	7.78e-06	0.000113	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EDNRA—migraine	7.56e-06	0.00011	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR2A—migraine	7.48e-06	0.000109	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TGFBR2—migraine	7.46e-06	0.000109	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOTCH3—migraine	7.37e-06	0.000108	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CACNA1A—migraine	7.34e-06	0.000107	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CALCA—migraine	7.28e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—ESR1—migraine	7.28e-06	0.000106	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—ESR1—migraine	7.22e-06	0.000105	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ESR1—migraine	7.07e-06	0.000103	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR7—migraine	6.81e-06	9.94e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ESR1—migraine	6.64e-06	9.69e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR2A—migraine	6.07e-06	8.86e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TGFBR2—migraine	5.87e-06	8.56e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—MTHFR—migraine	5.7e-06	8.31e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ESR1—migraine	5.39e-06	7.86e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2A—migraine	4.77e-06	6.96e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ESR1—migraine	4.23e-06	6.18e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—MTHFR—migraine	3.94e-06	5.75e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—MTHFR—migraine	2.43e-06	3.54e-05	CbGpPWpGaD
